Kelly A. Romano, Director at Athira Pharma, Inc. (ATHA), bought 8,000 shares at $13.11 ($105K) on 2022-03-31, disclosed to the SEC on 2022-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |